Park Ha Biological Technology is trading 10.3% down at $0.33 amid thin after-hours liquidity with no clear fundamental catalyst.
- The stock declined from its July 31 regular-session close of $0.37.
- No fresh company or sector headlines, regulatory filings, or earnings reports were identified to explain the price action.
- The move appears tied to low trading volume in the post-market session rather than material news.